Norwegian Cardio-Respiratory Arrest Study
NORCAST
1 other identifier
observational
261
1 country
1
Brief Summary
The purpose of this study is to evaluate the use of combined clinical-neurological, neurophysiologic, neuroradiological and biochemical markers in prognostication after cardio- and/or respiratory arrest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 10, 2010
CompletedFirst Posted
Study publicly available on registry
November 11, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
ExpectedApril 5, 2024
April 1, 2024
7.9 years
November 10, 2010
April 4, 2024
Conditions
Eligibility Criteria
Patients admitted after pre-hospital cardio/respiratory arrest.
You may qualify if:
- prehospital cardial resuscitation
- prehospital pulmonary resuscitation
- ROSC before/on admission to hospital
- \> 18 years of age
You may not qualify if:
- death on admission to hospital
- arrhythmic cardiac arrest with ALS \< 5min and spontaneous awakening
- in-hospital cardiac arrest
- trauma patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oslo University Hospital - Ulleval
Oslo, 0407, Norway
Related Publications (3)
Beitland S, Nakstad ER, Berg JP, Troseid AS, Brusletto BS, Brunborg C, Lundqvist C, Sunde K. Urine beta-2-Microglobulin, Osteopontin, and Trefoil Factor 3 May Early Predict Acute Kidney Injury and Outcome after Cardiac Arrest. Crit Care Res Pract. 2019 May 7;2019:4384796. doi: 10.1155/2019/4384796. eCollection 2019.
PMID: 31205786DERIVEDBeitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Troseid AS, Brusletto BS, Brunborg C, Andersen GO, Sunde K. Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest. Crit Care. 2016 Oct 5;20(1):314. doi: 10.1186/s13054-016-1503-2.
PMID: 27716377DERIVEDStaer-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Draegni T, Jacobsen D, Sunde K, Andersen GO. Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest. Circ Cardiovasc Interv. 2015 Oct;8(10):e002784. doi: 10.1161/CIRCINTERVENTIONS.115.002784.
PMID: 26453688DERIVED
Biospecimen
Serum, plasma, blood (PaxGene). For future identification of biochemical markers in prognostication after cardiorespiratory arrest. For future identification of biochemical markers for cardiac arrest (primarily serum, but also on mRNA-level).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dag Jacobsen, MD, PhD
Oslo University Hospital - Ulleval, Norway
- STUDY DIRECTOR
Kjetil Sunde, MD, PhD
Oslo University Hospital - Ulleval, Norway
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 10, 2010
First Posted
November 11, 2010
Study Start
September 1, 2010
Primary Completion
August 1, 2018
Study Completion (Estimated)
December 1, 2028
Last Updated
April 5, 2024
Record last verified: 2024-04